The STRAW+10 Stages, In Detail

"Where am I in this?" is the question every midlife woman eventually asks, and for years the medical field answered it with three blurry words — peri, menopause, post. In 2011 a group of researchers replaced the blur with a formal map: STRAW+10, the Stages of Reproductive Aging Workshop staging system. This page walks the map stage by stage, shows which criteria you can track yourself without a single lab draw, and is honest about what a stage can and cannot tell you.

Why Reproductive Aging Needed a Map

Before STRAW+10, "perimenopause" meant different things to different clinicians — and "menopause" was whatever the speaker decided it was. The 2011 workshop (an update of the original 2001 staging) fixed this by anchoring everything to a single event: the final menstrual period, or FMP — the last period a woman ever has, identifiable only after twelve consecutive period-free months (Harlow et al., Menopause, 2012). Stages before the FMP get negative numbers; stages after it get positive ones. The classification rests on three kinds of criteria: primary (menstrual cycle patterns), supportive (hormone markers like FSH and AMH), and descriptive (symptoms like hot flashes). The design choice that makes the map usable in real life: the primary criteria are things you can record on a calendar, not assays you need a lab for.

The full system adds a few more waypoints: stages -5 through -3b cover the reproductive years (regular cycles, only subtle hormonal drift), and +1b bridges the first two post-FMP years. The table above keeps the six stops that matter most for the transition itself. The pattern to notice: cycle criteria lead, labs follow. A woman in stage -2 can have a perfectly normal FSH on any given day — and a woman in -1 can show a spike that looks premenopausal.

The Two Criteria You Can Actually Use

Stripped of its machinery, STRAW+10 runs on two rules you can apply with a period-tracking app or a paper calendar:

• 📅 The seven-day rule (stage -2). Early transition begins when the length of consecutive cycles differs persistently by seven days or more — say, 28 days, then 21, then 33, and the irregularity sticks around. One odd cycle is not a stage; the persistence is.
• 🗓️ The sixty-day rule (stage -1). Late transition begins with the first gap of sixty or more days between periods. This is the runway's final stretch — the FMP typically arrives within one to three years.
• 🧪 Why FSH single draws mislead. During the transition, FSH swings with every cycle's attempt at ovulation. A single "normal" FSH does not mean you are not in the transition, and a single "high" FSH does not mean it is over. The staging criteria treat FSH as supportive for exactly this reason.
• 🔙 The retrospective anchor. You never know you are in +1a until the twelve-month mark arrives and you can look back and name the FMP. The system is honest about this: the map is drawn backward from a point you cannot see coming.

Locating Yourself on the Map

The practical exercise: track the first day of each period for a few months, then ask three questions. Are consecutive cycles differing by a week or more, consistently? That places you in early transition. Has a gap of sixty-plus days appeared? That is late transition. Has it been twelve full months? That is postmenopause, and the last period before the gap was your FMP. Two special cases bend the map. If the transition starts before age 40, the label changes to premature ovarian insufficiency and the staging vocabulary mostly gives way to a medical workup — a clinician conversation, not a calendar exercise. And if both ovaries are removed surgically, there is no runway at all: hormone levels fall within days, and symptoms arrive abruptly, which is its own clinical situation.

What the Stage Tells You, and What It Doesn't

The stage is genuinely useful — and limited in exactly the ways a map should be limited. What it tells you: where symptoms concentrate. Hot flashes typically begin in late transition and peak in the early postmenopause years (the +1c window above); sleep and mood shifts cluster in the same stretch, which is why the symptom catalog and the sleep and mood topic both hang their timelines on this staging. It also tells you when the risk curves start bending: bone loss accelerates from late transition onward, the story the Bone Health topic owns. What the stage does not tell you: how much you will suffer, how fast you will cross, or what you should do. There is no treatment algorithm attached to any stage — the hormone therapy question is decided by symptoms, age, and individual risk, and the Hormone Therapy topic walks that decision on its own terms. A stage is a description, not a diagnosis and not a duty.

Questions, Answered Briefly

• ❓ My cycles are irregular at 43 — am I early? Not necessarily — the transition commonly opens in the early-to-mid 40s, so irregularity there is typical timing. The stage criteria still apply: the seven-day rule marks early transition at any age. Cycles that stop entirely before 40 are a different, clinician-level conversation.
• 🧪 My doctor ordered an FSH test — is that staging? A single FSH draw cannot stage you during the transition; it is too variable. Postmenopausally it can confirm the new steady state. The hormone timeline page explains when labs actually help.
• 📅 How long will late transition last? For most women the final period arrives within a couple of years of the first sixty-day gap — but "most" is doing honest work there; individual ranges run wider.
• 🔄 Can I skip stages? The stages are descriptive bins, not checkpoints — you cross them whether or not anyone names them. Surgical menopause skips the runway; natural transitions never do.
• 🗣️ Does my clinician use this vocabulary? Many do, but if yours doesn't, the stage names matter less than the two criteria — the seven-day rule and the sixty-day gap — which you can bring to any visit as plain calendar facts.

Related Topics